Logo

LC/MS

Alzheimer's Disease-Related Proteins Picked up in Proteome-Wide Association Study

Starting with a search for genetic factors linked to brain protein levels, investigators identified 11 candidate genes that may be causal in Alzheimer's disease.

Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry
Premium

Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.

Thermo Fisher, Cedars-Sinai to Collaborate on Protein Mass Spec Workflows for Clinical Research

The partners plan to develop a number of liquid chromatography mass spectrometry methods for clinical research applications.

Thermo Fisher Partners with Newomics, Evosep, Biognosys on New Mass Spec Workflows

The company announced the collaborations this week in conjunction with the annual American Society for Mass Spectrometry Conference in Atlanta.

Omic, Microscopic Analysis Elucidates Otzi's Last Meal

An analysis of stomach and gastrointestinal samples suggests the Iceman munched on a high-fat diet of ibex, red deer, and einkorn plants before his final hike.

Jun 21, 2018

Systems Biology Study of Alzheimer's Disease Supports Ties to Virus

Mar 9, 2018

New Stomach Cancer Subtypes Uncovered With Proteomics

May 4, 2016

Newborn Screening Method Uses Mass Spec to Test for Niemann-Pick Disease Type C

Apr 29, 2016

Potential Regulation of Clinical LC/MS Tests to be Discussed at FDA Workshop Next Week
Premium

Apr 27, 2016

Agilent Opens Proteomics Lab With Australia's Monash University in Malaysia

Apr 6, 2016

Age-Associated Blood Metabolite Levels Revealed Through Mass Spec Study
Premium

Mar 14, 2016

FDA Announces Public Workshop on LC/MS-Based IVD Test Validation, Requests Comments

Mar 1, 2011

Eli Lilly Transfers Bioanalytical Drug Discovery Capabilities to Advion

Aug 18, 2009

Agilent's Q3 Bio-analytical Revenues Fall 8 Percent amid 27 Percent Total Revenue Decline

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.